Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection

Journal of Experimental Medicine

Volumn 195, Issue 9, 2002, Pages 1089-1101

  Reignat, Stephanie ^a   Webster, George J M ^b   Brown, David ^b   Ogg, Graham S ^c   King, Abigail ^c   Seneviratne, Suranjith L ^c   Dusheiko, Geoff ^b   Williams, Roger ^a   Maini, Mala K ^a   Bertoletti, Antonio ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Chronic hepatitis B; Cytotoxic T lymphocytes; Immune tolerance; Viral diseases; Viral T antigen

Indexed keywords

CD8 ANTIGEN; HLA ANTIGEN; T LYMPHOCYTE RECEPTOR; TETRAMER; VIRUS ANTIGEN;

ANTIGEN BINDING; ARTICLE; CELL POPULATION; CELL PROLIFERATION; CELL STIMULATION; CELL SURVIVAL; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOLOGICAL TOLERANCE; PRIORITY JOURNAL; VIRUS LOAD;

EID: 0037029652     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20011723     Document Type: Article

References (59)

1. Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo
2. Viral strategies of immune evasion
3. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells
4. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes
5. + T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients
6. Analysis of succesful immune responses in person infected with hepatitis C virus
7. + T cells with a defect in effector function that is reversible on extented IL-2 incubation
8. + T cells produce antiviral cytokines but are impaired in cytolytic function
9. Viral immune evasion due to persistence of activated T cells without effector function
10. Critical role for α/β and γ interferons in persistence of lymphocytic choriomeningitis virus by clonal exhaustion of cytotoxic T cells
11. Assessing CD8 T cell number and dysfunction in the presence of antigen
12. Hepatitis B virus biology
13. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope
14. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells
15. Posttranscriptional inhibition of class I major histocompatibility complex presentation on hepatocytes and lymphoid cells in chronic woodchuck hepatitis virus infection
16. Hepatitis B virus immunopathogenesis
17. Immunogenicity of hepatitis B virus vaccine in healthy Chinese neonates
18. Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection
19. Lamivudine treatment can overcome cytotoxic T cell hyporesponsiveness in chronic hepatitis B: New perspective for immune therapy
20. + cells in viral control and liver damage during persistent hepatitis B virus (HBV) infection
21. + T lymphocyte differentiation as a mechanism for subdominant cytotoxic T lymphocyte responses to a viral antigen
22. Recombinant modified vaccinia Ankara efficiently restimulates human cytotoxic T lymphocytes in vitro
23. + T cell responses in neonatal mice: Susceptibility to polyoma virus-induced tumors is associated with lack of cytotoxic function by viral antigen-specific T cells
24. + T cells
25. Increased TCR avidity after T cell activation: A mechanism for sensing low-density antigen
26. Specificity of CTL interactions with peptide-MHC class I tetrameric complexes is temperature dependent
27. + T cells closely correlates with CD56 surface expression
28. A functional and kinetic comparison of antiviral effector and memory cytotoxic T lymphocyte populations in vivo and in vitro
29. + T lymphocytes but fail to promote survival
30. + T cells within the liver
31. Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T cell tolerance
32. Initiation of signal transduction through the T cell receptor requires the peptide multivalent engagement of MHC ligands
33. The relationship of MHC-peptide binding and T cell activation probed using chemically defined MHC class II oligomers
34. CD8 expression allows T cell signaling by monomeric peptide-MHC complexes
35. Stability and diversity of T cell receptor repertoire usage during lymphocytic choriomeningitis virus infection of mice
36. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
37. An antigen detected in the blood during the incubation period of serum hepatitis
38. Australia antigen detected in nuclei of liver cells of patients with viral hepatitis by fluorescent antibody technique
39. Purification and biophysical characterization of hepatitis B antigen
40. Tracing and characterisation of the low-avidity self-specific T cell repertoire
41. Discrepancy between ELISPOT IFN-γ secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life
42. - T lymphocytes that persist after peripheral tolerance to a self antigen expressed in the pancreas
43. + T cells without selection of higher affinity TCR
44. Two intermediate-avidity cytotoxic T lymphocyte clones with a disparity between functional avidity and MHC tetramer staining
45. TCR avidity: It's not how strong you make it, it's how you make it strong
46. T cell affinity maturation by selective expansion during infection
47. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: Role of anti-self (virus) immune response
48. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice
49. Immune surveillance against a solid tumor fails because of immunological ignorance
50. Antigenic cancer cells grow progressively in immune hosts without evidence of T cell exhaustion or systemic anergy
51. Break of T cell ignorance to a viral antigen in the liver induces hepatitis
52. Overcoming T cell tolerance to the hepatitis B virus surface antigen in hepatitis B virus-transgenic mice
53. DNA-mediated immunization in a transgenic mouse model for the hepatitis B surface antigen chronic carrier state
54. Detection of hepatitis B virus antigens in liver tissue
55. Specific vaccine therapy in chronic hepatitis B: Induction of T cell proliferative responses specific for envelope antigens
56. Efficacy and limitations of a specific immunotherapy in chronic hepatitis B
57. DNA prime/canarypox boost-based immunotherapy of chronic hepatitis B virus infection in a chimpanzee
58. Protective and therapeutic effect of DNA-based immunization against hepadnavirus large envelope protein
59. Self antigens expressed by solid tumors do not efficiently stimulate naive or activated T cells: Implications for immunotherapy